EFPIA - NEWSLETTER

EFPIA Newsletter 02 April 2026

News

31 March 2026 EFPIA statement on the conclusions of the EU-India Free Trade Agreement (FTA) negotiations

EFPIA welcomes the EU’s continued efforts to strengthen trade ties with strategic partners at a time of growing geopolitical...

Blogs

30 March 2026 When Chemical policy meets patient care: Why the PFAS debate needs a closer look at medicines...

Europe is in the middle of one of the most ambitious chemical regulatory debates in its history.

POLITICO’s Competitive Europe Summit: watch the event recording

OPENING REMARKS by Stefan Oelrich, President of EFPIA and Pharmaceuticals at Bayer AG | POLITICO

On 24 March, EFPIA took part in POLITICO’s Competitive Europe Summit, at a pivotal moment for Europe’s future. With the EU at a crossroads, discussions focused on whether Europe can reform, drive growth and reclaim global influence - or risk stagnation, undermining both its economic strength and security.

FIRESIDE CHAT | Health: Can Europe lead the world’s Pharma market? | POLITICO

In a fireside chat on Europe’s global competitiveness in pharmaceuticals, Padraic Ward, Head of Roche Pharma International, highlighted the need for a critical mindset shift.

Europe’s Choice: Investing in sustainable health systems | 21 April

European health and social care systems are under intense pressure.

With strained budgets, growing pressure on public finances, a deepening workforce crisis, and an uncertain geopolitical landscape, the need to rethink healthcare in Europe has never been more urgent.

Join us on 21 April to discuss how Health Checks for cardiometabolic risk factors can transform prevention, reduce avoidable disease, and lower long-term costs.

Discover the programme and register here.

What we are reading

Drugmakers delay some European launches with a wary eye on Trump's pricing policies 31 March 2026 (Reuters)

Europe’s wastewater Rubik’s Cube: Can Commission and industry align data? 27 March 2026 (Euractiv)

Czech minister warns EU, wastewater rules risk limiting medicines access 27 March 2026 (Euractiv)

The Most Favored Nation Policy: early insights into Europe’s response 25 March 2026 (Pharmaceutical Technology)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶